Improving therapeutic effect in ovarian peritoneal carcinomatosis with honokiol nanoparticles in a thermosensitive hydrogel composite

Epithelial Ovarian Cancer

(2017) Robert J. Morgan et al.   Journal of the National Comprehensive Cancer Network

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway

(2012) J.-W. Lin et al.   NEURO-ONCOLOGY

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

(2011) Lisa M. Landrum et al.   GYNECOLOGIC ONCOLOGY

Honokiol produces anti-neoplastic effects on melanoma cells in vitro

(2011) Patrick W. Mannal et al.   JOURNAL OF SURGICAL ONCOLOGY

Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells

(2011) Sumit Arora et al.   PLoS One

Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic drug delivery, part 2: in vitro and in vivo toxicity evaluation

(2010) ChangYang Gong et al.   JOURNAL OF NANOPARTICLE RESEARCH

Biodegradable self-assembled PEG–PCL–PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization

(2010) ChangYang Gong et al.   NANOTECHNOLOGY

Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells

(2010) Yao Wang et al.   TOXICOLOGY MECHANISMS AND METHODS

Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells

(2009) Ling-Li Han et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies

(2009) Siobhan M. Kehoe et al.   GYNECOLOGIC ONCOLOGY

Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer

(2009) Peter J. Frederick et al.   GYNECOLOGIC ONCOLOGY

Thermosensitive PEG–PCL–PEG Hydrogel Controlled Drug Delivery System: Sol–Gel–Sol Transition and In Vitro Drug Release Study

(2009) Chang Yang Gong et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Novel Composite Drug Delivery System for Honokiol Delivery: Self-Assembled Poly(ethylene glycol)−Poly(ε-caprolactone)−Poly(ethylene glycol) Micelles in Thermosensitive Poly(ethylene glycol)−Poly(ε-caprolactone)−Poly(ethylene glycol) Hydrogel

(2009) ChangYang Gong et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model

(2008) Qi-qi Jiang et al.   BMC CANCER

Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells

(2008) Zhengyu Li et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel

(2008) C GONG et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

(2008) Hong Luo et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Preparation and characterization of honokiol nanoparticles

(2008) Ma Ling Gou et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: A review of complications and completion rates

(2007) Lisa M. Landrum et al.   GYNECOLOGIC ONCOLOGY

Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma

(2007) Y. LIU et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER